Appropriate use of the anti-methicillin-resistant Staphylococcus aureus agents in retrospective study

Yakugaku Zasshi

Volumn 128, Issue 7, 2008, Pages 1073-1079

  Nakamura, Yasutaka ^a   Yokoyama, Iichirou ^a   Hashimoto, Noriko ^a   Hasegawa, Atsushi ^a   Nakasa, Hiromitsu ^a   Nakamura, Hiroyoshi ^a   Watanabe, Masaharu ^a   Nomura, Fumio ^a   Watanabe, Akira ^a   Igari, Hidetoshi ^a   Sato, Takeyuki ^a   Nakazawa, Kazuyoshi ^a   Ariyoshi, Noritaka ^a   Kitada, Mitsukazu ^a  

^a CHIBA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Anti methicillin resistant staphylococcus aureus agents (anti MRSA agents); Arbekacin sulfate (ABK); Teicoplanin (TEIC); Therapeutic drug monitoring (TDM); Vancomycin hydrochloride (VCM)

Indexed keywords

C REACTIVE PROTEIN; HABEKACIN; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BODY TEMPERATURE; DRUG BLOOD LEVEL; DRUG MONITORING; HUMAN; LEUKOCYTE COUNT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; RETROSPECTIVE STUDY; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; DIBEKACIN; DRUG MONITORING; DRUG RESISTANCE, BACTERIAL; HUMANS; METHICILLIN RESISTANCE; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TEICOPLANIN; TIME FACTORS; VANCOMYCIN;

EID: 46849111411     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.128.1073     Document Type: Article

References (21)

1. Ishii Y., Ohno S., Kanshitani S., Iwata M., Yamaguchi K., J. Infect. Chemother., 2, 102-105 (1996).
2. Fujita N., Komori T., Tanimoto M., Yoshimura M., Ike Y., Infecti. Control, 6, 242-243 (1997).
3. CDC., Staphylococcus aureus resistant to vancomycin., United States., Morb. Mortal. Wkly. Rep., 51, 565-567 (2002).
4. CDC., Vancomycin-resistant Staphylococcus aureus., Pennsylvania., Morb. Mortal. Wkly. Rep., 51, 902 (2002).
5. Clinical and Laboratory Standards Institute; Performance Standards for Antimicrobial Susceptibility Testing, Seventeenth Informational Supplement M100-S17. Clinical and Laboratory Standards Institute, Wayne, Pa. (2007).
6. CDC., Guideline for isolation precautions in hospitals (1996).
7. Kokubo H., Kimura T., Yago K., Yakugaku Zasshi., 127, 925-929 (2007).
8. Hasegawa A., Watanabe T., Kimura M., J. Jpn. Soc. Hosp. Pham., 35, 955-958 (1999).
9. Sato S., Saito Y., Sato H., J. Soc. Microb. Ecol., 15, 111-119 (2005).
10. Tanihara K., Jpn. J. TDM, 18, 85-86 (2001).
11. Kaku M., Jpn. J. TDM, 18, 79-80 (2001).
12. Craig W. A., Clin. Inf. Dis., 26, 1-10 (1998).
13. Matzke G. R., Zhanel G. G., Guay D. R., Clin. Pharmacokinet., 11, 257-282 (1986).
14. Rybak M. J., Albrecht L. M., Boike S. C., Chandrasekar P. H., J. Antimicrod. Chemother., 25, 679-687 (1990).
15. Rowland M., Clin. Pharmacokinet., 18, 184-209 (1990).
16. Arakawa S., Yamashita K., Li M., Kankyo-Kansen, 21, 17-23 (2006).
17. Ueda Y., Noguchi S., Maki M., Jpn. J. Chemother., 55, 8-16 (2007).
18. Sato M., Chida K., Suda T., J. Infect. Chemother., 12, 185-189 (2006).
19. Sakai T., Momochi C., Shiomi K., J. Jpn. Soc. Hosp. Pham., 39, 51-53 (2003).
20. Nambara M., Ikeue H., Kawasaki E., Jpn. J. TDM, 20, 241-248 (2003).
21. Kobayashi M., Saikyo A., Soma K., Jpn. J. Chemother., 54, 18-24 (2006).